The clinivation Global^® xi enterprise solution for Market Clearance Management enables executives and their teams to address the challenges of execution, effective governance, and lean business performance in their global market clearance operations. By enabling excellence in global market clearance operations to advance the revenue intrinsic to market clearance success, clinivation Global^® xi liberates revenue that's trapped-in-process.

Headquartered in San Carlo, California, Natus Medical is a leading provider of healthcare products used for the screening, detection, treatment, monitoring, and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and newborn care. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, and software systems for managing and tracking disorders and diseases for public health laboratories. Natus sells its products in the U.S. and over 100 countries worldwide. In 2008 Natus was named by Fortune magazine as one of the nation's fastest growing small public companies. For more information, please visit www.natus.com

Clinivation is the leading provider of integrated solutions that enable global market clearance. Guided by our singular vision - "Excellence in Market Clearance" - clinivation accelerates the entire market clearance cycle to advance new worldwide revenue and achieve new milestones of enterprise value.

Used in over 100,000 product registrations by more than 100 companies worldwide, clinivation's end-to-end technology and services deliver on our vision by eliminating revenue traps from global market clearance operations, increasing process velocity with on-demand regulatory intelligence, automating clearance-driven business controls, simplifying content unification into market clearance applications, aligning quality systems with global market clearance priorities, streamlining clinical development with clearance-focused trials, and enabling management with key performance indicators for continuous improvement and effective governance.

The world's leading medical device, diagnostics, hospital supply, and dental supply companies select clinivation because of our medtech industry focus and our unique, integrated solutions that seamlessly adapt to existing business processes and enterprise infrastructure- without the need to write custom code.

Our core brands include the clinivation Global^® xi market clearance platform, clinivation WorldView^® on-demand regulatory intelligence, and clinivation Clinical Suite^® and clinivation Registry Suite^® electronic data capture and clinical data management software.

Founded in 1999, the company is headquartered in Natick, Massachusetts, with regional offices in North America and Asia.

Visit clinivation online at www.clinivation.com

For more information on clinivation's integrated solutions that enable global market clearance, please click here or call us at 508.655.6560.